FY2027 EPS Estimates for Spectral AI Increased by Analyst

Spectral AI, Inc. (NASDAQ:MDAI) – Stock analysts at HC Wainwright upped their FY2027 earnings per share (EPS) estimates for Spectral AI in a research report issued on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of $0.63 per share for the year, up from their previous estimate of $0.53. HC Wainwright currently has a “Buy” rating and a $3.50 target price on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.64) per share. HC Wainwright also issued estimates for Spectral AI’s FY2028 earnings at $0.46 EPS.

Spectral AI (NASDAQ:MDAI) last issued its quarterly earnings data on Monday, August 12th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $7.48 million during the quarter, compared to the consensus estimate of $6.00 million.

Several other analysts have also issued reports on MDAI. Northland Securities assumed coverage on Spectral AI in a research note on Monday, August 12th. They issued an “outperform” rating and a $6.00 target price for the company. Northland Capmk raised Spectral AI to a “strong-buy” rating in a research note on Monday, August 12th.

Spectral AI Price Performance

Shares of MDAI opened at $1.35 on Friday. The firm has a market cap of $24.99 million, a P/E ratio of -2.08 and a beta of 0.48. The stock has a 50 day simple moving average of $1.26 and a two-hundred day simple moving average of $1.54. Spectral AI has a 1 year low of $0.82 and a 1 year high of $3.72.

Institutional Trading of Spectral AI

Several hedge funds and other institutional investors have recently bought and sold shares of MDAI. Murchinson Ltd. bought a new stake in Spectral AI in the first quarter valued at approximately $85,000. Forum Financial Management LP bought a new position in shares of Spectral AI during the second quarter valued at approximately $51,000. Finally, Virtu Financial LLC bought a new position in shares of Spectral AI during the first quarter valued at approximately $38,000. Institutional investors own 67.08% of the company’s stock.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.